Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

LY 233053

Name LY 233053
Supplier R&D Systems
Catalog 1521
Prices $89.00, $185.00, $755.00
Sizes 1 mg, 10 mg, 50 mg
Cas Number 125546-04-5
Chemical Name (2R*,4S*)-4-(1H-Tetrazol-5-ylmethyl)-2-piperidinecarboxylicacid
Formula C8H13N5O2
Molecular Weight 211.22
Purity >99%
Supplier Page Shop

Product References

Pharmacological characterization of LY233053: a structurally novel - Pharmacological characterization of LY233053: a structurally novel

Schoepp DD, Ornstein PL, Leander JD, Lodge D, Salhoff CR, Zeman S, Zimmerman DM. J Pharmacol Exp Ther. 1990 Dec;255(3):1301-8.

Efficacy of LY233053, a competitive glutamate antagonist, in experimental central - Efficacy of LY233053, a competitive glutamate antagonist, in experimental central

Madden KP, Clark WM, Kochhar A, Zivin JA. J Neurosurg. 1992 Jan;76(1):106-10.

Delayed therapy of experimental ischemia with competitive N-methyl-D-aspartate - Delayed therapy of experimental ischemia with competitive N-methyl-D-aspartate

Madden KP, Clark WM, Zivin JA. Stroke. 1993 Jul;24(7):1068-71.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved